Koers Lexagene Holdings Inc Toronto S.E.
Aandelen
WEY
CA52886L1031
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01-03-18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24-03-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18-06-18 |
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Tom Slezak
BRD | Director/Board Member | - | 12-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-39,86% | 8,15 mld. | |
+7,39% | 3,6 mld. | |
-1,48% | 2,27 mld. | |
-26,02% | 1,9 mld. | |
-20,07% | 1,72 mld. | |
+8,09% | 922 mln. | |
+19,92% | 731 mln. | |
-12,45% | 679 mln. | |
-29,39% | 503 mln. |